Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Todd Neale

November 29, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Shelley Wood

August 11, 2022

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Features

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Todd Neale

June 24, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Conference News ACC 2022

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

Michael O'Riordan

April 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

Advertisement

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 2022 News Roundup

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

July 2022 News Roundup

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

More Support for Single Antiplatelet Therapy After TAVI

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

May 2022 News Roundup

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content